A Study to Extend the Registry of Inflammatory Diseases of the Central Nervous System
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 14-003720
Sponsor Protocol Number: 14-003720
About this study
The purpose of this study is to extend enrollment and follow up of participants in a registry for inflammatory diseases of the central nervous system.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Must have a disease of the central nervous system considered by the treating clinician to be inflammatory in nature
- Neuromyelitis optica
- Optic neuritis
- Transverse myelitis
- Paraneoplastic central nervous system disorders
- Multiple sclerosis
- Inflammatory central nervous system diseases not otherwise specified
- And must have been a participant in the CNS Repository IRB#08-007846
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Sean Pittock, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available